Your browser doesn't support javascript.
loading
Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes.
Levy-Mendelovich, Sarina; Atia, Nitzan; Budnik, Ivan; Barg, Assaf Arie; Avishai, Einat; Cohen, Omri; Brutman-Barazani, Tami; Livnat, Tami; Kenet, Gili.
Afiliação
  • Levy-Mendelovich S; National Hemophilia Center and Coagulation Unit, Sheba Medical Center, Tel Hashomer, Israel.
  • Atia N; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Budnik I; The Sheba Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel.
  • Barg AA; National Hemophilia Center and Coagulation Unit, Sheba Medical Center, Tel Hashomer, Israel.
  • Avishai E; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cohen O; Department of Internal Medicine, Division of Hematology/Oncology, University of Iowa, Iowa City, Iowa, USA.
  • Brutman-Barazani T; National Hemophilia Center and Coagulation Unit, Sheba Medical Center, Tel Hashomer, Israel.
  • Livnat T; Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Kenet G; National Hemophilia Center and Coagulation Unit, Sheba Medical Center, Tel Hashomer, Israel.
Res Pract Thromb Haemost ; 7(4): 100278, 2023 May.
Article em En | MEDLINE | ID: mdl-37538499

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel País de publicação: Estados Unidos